Cost-utility of a cardiovascular prevention program in highly educated adults: Intermediate results of a randomized controlled trial

International Journal of Technology Assessment in Health Care

Volumn 26, Issue 1, 2010, Pages 11-19

  Jacobs, Nele ^a   Evers, Silvia ^b   Ament, Andre ^b   Claes, Neree ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Behavior; Cardiovascular prevention; Cost effectiveness; Cost utility

Indexed keywords

BEHAVIOR; CARDIOVASCULAR PREVENTION; COST DATA; COST-UTILITY ANALYSIS; INCREMENTAL COST; INTERMEDIATE RESULTS; MEDICAL INTERVENTION; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIAL; RISK FACTORS;

COST EFFECTIVENESS; COSTS; SENSITIVITY ANALYSIS;

COST BENEFIT ANALYSIS;

ADULT; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; AGED; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIET; ECONOMICS; EXERCISE; HEALTH BEHAVIOR; INTERNET; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SMOKING;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; SMOKING;

EID: 77949877844     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309990845     Document Type: Article

References (28)

1. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055-1068.
2. Ajzen I. Theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179-211.
3. Annemans L, Lamotte M, Clarys P, Van Den Abeele E. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Eur J Cardiovasc Prev Rehabil. 2007;14:815-824.
4. Bemelmans W, van Baal P, Wendel-Vos W, et al. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action. Prev Med. 2008;46:127-132.
5. Brazier J, Roberts J,DeverillM. The estimation of a preferencebased measure of health from the SF-36. J Health Econ. 2002;21:271-292.
6. Claes N, Jacobs N. The PreCardio-study protocol-a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme. BMC Cardiovasc Disord. 2007;7:27.
7. Claes N, Moeremans K, Frank B, et al. Estimating the costeffectiveness of quality-improving interventions in oral anticoagulation management within general practice. Value Health. 2006;9:369-376.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610.
9. De Bacquer D, De Backer G. The prevalence of concomitant hypertension and hypercholesterolaemia in the general population. Int J Cardiol. 2006;110:217-223.
10. Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn. 2007;3:101-129.
11. Graves N, McKinnon L, Reeves M, et al. Cost-effectiveness analyses and modelling the lifetime costs and benefits of healthbehaviour interventions. Chronic Illn. 2006;2:97-107.
12. Grover SA, Coupal L, Lowensteyn I. Determining the costeffectiveness of preventing cardiovascular disease: Are estimates calculated over the duration of a clinical trial adequate? Can J Cardiol. 2008;24:261-266.
13. Gusi N, Reyes MC, Gonzalez-Guerrero JL, et al. Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: A randomised controlled trial. BMC Public Health. 2008;8:231.
14. Jacobs N, Claes N. An autonomy-supporting cardiovascular prevention programme: Practical recommendations from selfdetermination theory. Eur Health Psychol. 2008;10:74-76.
15. Kroeze W,WerkmanA,Brug J.Asystematic reviewof randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006;31:205-223
16. Leal J, Luengo-Fernandez R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610-1619. (Pubitemid 43954923)
17. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: The importance of controlling for baseline utility. Health Econ. 2005;14:487-496.
18. Munro JF, Nicholl JP, Brazier JE, et al. Cost effectiveness of a community based exercise programme in over 65 year olds: Cluster randomised trial. J Epidemiol Community Health. 2004;58:1004-1010.
19. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. Draft for consultation. London: NICE; 2007.
20. Ronckers ET, Groot W, Steenbakkers M, et al. Costs of the 'Hartslag Limburg' community heart health intervention. BMC Public Health. 2006;6:51.
21. RVZ. Zinnige en duurzame zorg. Zoetermeer: Raad voor de Volksgezondheid en Zorg; 2006.
22. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55:68-78.
23. van Keulen HM, Mesters I, Brug J, et al. Vitalum study design: RCT evaluating the efficacy of tailored print communication and telephone motivational interviewing on multiple health behaviors. BMC Public Health. 2008;8:216.
24. Vandelanotte C, De Bourdeaudhuij I, Sallis JF, et al. Efficacy of sequential or simultaneous interactive computer-tailored interventions for increasing physical activity and decreasing fat intake. Ann Behav Med. 2005;29:138-146.
25. Vandelanotte C, De Bourdeaudhuij I, Philippaerts R, Sjöström M, Sallis M. Reliability and validity of a computerized and Dutch version of the international physical activity questionnaire (IPAQ). J Phys Act Health. 2005;2:63-75.
26. Vandelanotte C, Matthys C, De Bourdeaudhuij I.Reliability and validity of a computerised questionnaire to measure fat intake in Belgium. Nutr Res. 2004;24:621-631.
27. Walters SJ, Brazier JE. Sample sizes for the SF-6D preference based measure of health from the SF-36: A comparison of two methods. Health Serv Outcomes Res Methodol. 2003;4:35-47.
28. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.